An A2A adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models.
Saved in:
| Title: | An A2A adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models. |
|---|---|
| Authors: | Moore CC (AUTHOR), Martin EN (AUTHOR), Lee GH (AUTHOR), Obrig T (AUTHOR), Linden J (AUTHOR), Scheld WM (AUTHOR), Moore, Christopher C1 (AUTHOR), Martin, Edward N (AUTHOR), Lee, Grace H (AUTHOR), Obrig, Tom (AUTHOR), Linden, Joel (AUTHOR), Scheld, W Michael (AUTHOR) |
| Source: | BMC Infectious Diseases. 2008, Vol. 8 Issue 1, p141-141. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
